Mechanism of increases inl-kynurenine and quinolinic acid in renal insufficiency
Open Access
- 1 September 2000
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 279 (3), F565-F572
- https://doi.org/10.1152/ajprenal.2000.279.3.f565
Abstract
Marked increases in metabolites of thel-tryptophan-kynurenine pathway, l-kynurenine and quinolinic acid (Quin), were observed in serum and cerebrospinal fluid (CSF) of both the rat and human with renal insufficiency. The mechanisms responsible for their accumulation after renal insufficiency were investigated. In patients with chronic renal insufficiency, elevated levels of serum l-kynurenine and Quin were reduced by hemodialysis. In renal-insufficient rats, Quin andl-kynurenine levels in serum, brain, and CSF were also increased parallel to the severity of renal insufficiency. Urinary excretion of Quin (3.5-fold) and l-kynurenine (2.8-fold) was also increased. Liver l-tryptophan 2,3-dioxygenase activity (TDO), a rate-limiting enzyme of the kynurenine pathway, was increased in proportion to blood urea nitrogen and creatinine levels. Kynurenine 3-hydroxylase and quinolinic acid phosphoribosyltransferase were unchanged, but the activities of kynureninase, 3-hydroxyanthranilate dioxygenase, and aminocarboxymuconate-semialdehyde decarboxylase (ACMSDase) were significantly decreased. Systemic administrations of pyrazinamide (ACMSDase inhibitor) increased serum Quin concentrations in control rats, demonstrating that changes in body ACMSDase activities in response to renal insufficiency are important factors for the determination of serum Quin concentrations. We hypothesize the following ideas: that increased serum l-kynurenine concentrations are mainly due to the increased TDO and decreased kynureninase activities in the liver and increased serum Quin concentrations are due to the decreased ACMSDase activities in the body after renal insufficiency. The accumulation of CSFl-kynurenine is caused by the entry of increased seruml-kynurenine, and the accumulation of CSF Quin is secondary to Quin from plasma and/or Quin precursor into the brain.Keywords
This publication has 32 references indexed in Scilit:
- Quantification of Local De Novo Synthesis Versus Blood Contributions to Quinolinic Acid Concentrations in Brain and Systemic TissuesJournal of Neurochemistry, 1997
- Free and protein-bound tryptophan in serum of untreated patients with chronic renal failureKidney International, 1993
- QUINOLINIC ACID AND KYNURENINE PATHWAY METABOLISM IN INFLAMMATORY AND NON-INFLAMMATORY NEUROLOGICAL DISEASEBrain, 1992
- Quinolinic acid: a modulator of the heart calcium channel in the rat and a binder of calcium ionsExperimental pathology, 1991
- Intestinal transport of pyrodoxine in experimental renal failureLife Sciences, 1989
- Brain metabolism of amino acids and ammonia in patients with chronic renal insufficiencyKidney International, 1981
- The effect of pyrazines on the metabolism of tryptophan and nicotinamide adenine dinucleotide in the rat Evidence of the formation of a potent inhibitor of aminocarboxy-muconate-semialdehyde decarboxylase from pyrazinamideBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- Brain monoamines in metabolic (endotoxic) coma a preliminary biochemical study in human postmortem materialJournal of Neural Transmission, 1977
- Pathogenesis and characterization of hyperglucagonemia in the uremic rat.JCI Insight, 1976
- EFFECT OF INCREASED RAT BRAIN TRYPTOPHAN ON 5‐HYDROXYTRYPTAMINE AND 5‐HYDROXYINDOLYL ACETIC ACID IN THE HYPOTHALAMUS AND OTHER BRAIN REGIONSJournal of Neurochemistry, 1974